| |
 |
|
Class Information
Number: 424/234.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.)
Description: Subject matter involving a bacterium, a component of a bacterium, or a substance produced by a bacterium.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 424/246.1 |
Bacillus |
69 |
| 424/253.1 |
Bordetella (e.g., bordetella bronchiseptica, etc.) |
69 |
| 424/252.1 |
Brucella (e.g., brucella abortus, brucella canis, etc.) |
31 |
| 424/263.1 |
Chlamydia (e.g., chlamydia trachomatis, etc.) |
78 |
| 424/247.1 |
Clostridium (e.g., clostridium tetani, clostridium difficile, clostridium perfringens, clostridium botulinum, clostridium chauvoei, etc.) |
98 |
| 424/245.1 |
Corynebacterium (e.g., corynebacterium diphtheriae, etc.) |
47 |
| 424/257.1 |
Escherichia (e.g., escherichia coli, etc.) |
150 |
| 424/256.1 |
Hemophilus (e.g., hemophilus influenzae, hemophilus gallinarum, hemophilus pleuropnemoniae, etc.) |
196 |
| 424/259.1 |
Klebsiella (e.g., klebsiella pneumoniae, etc.) |
30 |
| 424/251.1 |
Moraxella (e.g., moraxella bovis, etc.) |
55 |
| 424/248.1 |
Mycobacterium (e.g., mycobacterium tuberculosis, calmette-guerin bacillus (i.e., bcg), etc.) |
233 |
| 424/264.1 |
Mycoplasma |
46 |
| 424/249.1 |
Neisseria (e.g., neisseria gonorrhoeae, etc.) |
93 |
| 424/255.1 |
Pasteurella (e.g., pasteurella multocida, pasteurella hemolytica, etc.) |
88 |
| 424/242.1 |
Pilus, fimbria, or adhesin |
81 |
| 424/260.1 |
Pseudomonas (e.g., pseudomonas aeruginosa, etc.) |
90 |
| 424/258.1 |
Salmonella (e.g., salmonella typhimurium, etc.) |
142 |
| 424/243.1 |
Staphylococcus (e.g., staphylococcus aureus, etc.) |
107 |
| 424/244.1 |
Streptococcus (e.g., group b streptococcus, pneumococcus or streptococcus pneumoniae, etc.) |
300 |
| 424/236.1 |
Toxin or toxoid, except endotoxin (e.g., exotoxin, enterotoxin, etc.) |
329 |
| 424/235.1 |
Transposon mutant or deletion mutant bacterium (e.g., produced by transposon mutagenesis, etc.) |
94 |
| 424/262.1 |
Treponema (e.g., treponema hyodysenteriae, treponema pallidum, etc.) |
42 |
| 424/261.1 |
Vibrio (e.g., vibrio cholera, etc.) |
82 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 5858367 |
Methods for screening for antimicrobials utilizing AarC and compositions thereof |
Jan. 12, 1999 |
| 5859207 |
Superantigen agonist and antagonist peptides |
Jan. 12, 1999 |
| 5855901 |
Immunostimulating activity of Streptococcus pneumoniae serotype 8 oligosaccharides |
Jan. 5, 1999 |
| 5856447 |
Hybridomas producing antibodies specific for lyme disease antigens OspA and OspB |
Jan. 5, 1999 |
| 5853736 |
Potentiation of immunogenic response |
Dec. 29, 1998 |
| 5853738 |
Methods for treatment of human immunodeficiency virus infection with pseudomonas phosphoaminolipid extract |
Dec. 29, 1998 |
| 5853763 |
Method for delivering bioactive agents into and through the mucosally-associated lymphoid tissue and controlling their release |
Dec. 29, 1998 |
| 5853765 |
Anti-cholesterolemic egg, vaccine and method for production, and use |
Dec. 29, 1998 |
| 5849349 |
Anti-cholesterolemic egg, vaccine and method for production, and use |
Dec. 15, 1998 |
| 5849530 |
Manipulation of gene copy number in bordetella |
Dec. 15, 1998 |
| 5846540 |
Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
Dec. 8, 1998 |
| 5846547 |
Streptococcal C5a peptidase vaccine |
Dec. 8, 1998 |
| 5846789 |
Process for preparing nontoxic lipopolysaccharides from acidiphilium species |
Dec. 8, 1998 |
| 5846946 |
Compositions and methods for administering Borrelia DNA |
Dec. 8, 1998 |
| 5843460 |
Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides |
Dec. 1, 1998 |
| 5843462 |
Diphtheria toxin epitopes |
Dec. 1, 1998 |
| 5840315 |
Vaccines based on streptokinase |
Nov. 24, 1998 |
| 5837240 |
Multimeric, recombinant urease vaccine |
Nov. 17, 1998 |
| 5837263 |
Leptospira membrane proteins |
Nov. 17, 1998 |
| 5837264 |
Potentiation of immunogenic response |
Nov. 17, 1998 |
| 5830710 |
Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease |
Nov. 3, 1998 |
| 5824309 |
Recombinant gas vesicles and uses thereof |
Oct. 20, 1998 |
| 5821335 |
Biosynthetic gene murg from streptococcus pneumoniae |
Oct. 13, 1998 |
| 5814455 |
Antigen preparation for detecting H. pylori |
Sep. 29, 1998 |
| 5807553 |
Immonogenic oligosaccharide compositions |
Sep. 15, 1998 |
| 5804198 |
Vaccines against disease caused by pathogenic pilus-forming bacteria |
Sep. 8, 1998 |
| 5804199 |
Oil-based and water-based adjuvant mixture |
Sep. 8, 1998 |
| 5800821 |
Bacterial spores as a heat stable vaccine delivery system |
Sep. 1, 1998 |
| 5788962 |
DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures |
Aug. 4, 1998 |
| 5788985 |
Vaccine composition for eliciting an immune response against N-glycolylated gangliosides and its use for cancer treatment |
Aug. 4, 1998 |
| 5783196 |
Gua mutants of shigella spp. and vaccines containing the same |
Jul. 21, 1998 |
| 5783441 |
Gene and protein applicable to the preparation of vaccines for rickettsia prowazekii and rickettsia typhi and the detection of both |
Jul. 21, 1998 |
| 5780030 |
Passive vaccine against Lyme disease |
Jul. 14, 1998 |
| 5780040 |
Helicobacter pylori nickel binding protein |
Jul. 14, 1998 |
| 5780041 |
39-kilodalton antigen specific to Borrelia burgdorferi |
Jul. 14, 1998 |
| 5780424 |
Purified ribosomal fractions separated from the nonphotosynthetic filamentous bacteria beggiatoales |
Jul. 14, 1998 |
| 5773006 |
Lipsome containing IL-2 |
Jun. 30, 1998 |
| 5770212 |
Recombinant poxviruses with foreign DNA in essential regions |
Jun. 23, 1998 |
| 5766600 |
Non-azo naphtalimide dyes and uses for same |
Jun. 16, 1998 |
| 5766607 |
Method of culturing M. bovis in low available iron media and isolation of outer membrane proteins |
Jun. 16, 1998 |
| 5762941 |
Modified shigella having reduced pathogenicity |
Jun. 9, 1998 |
| 5762943 |
Methods of treating type I hypersensitivity using monophosphoryl lipid A |
Jun. 9, 1998 |
| 5763226 |
Bacillus cereus enterotoxin and method of use |
Jun. 9, 1998 |
| 5753234 |
Single-shot vaccine formulation |
May. 19, 1998 |
| 5747309 |
Bacterial vaccines using vaccine strains of pathogenic bacteria |
May. 5, 1998 |
| 5744134 |
Immunoglobulin and fiber-containing composition for human gastrointestinal health |
Apr. 28, 1998 |
| 5741494 |
Immunopotentiative and infection-protective agent containing bacillus and egg white |
Apr. 21, 1998 |
| 5733544 |
Nematicidal bacillus strain and metabolite and methods of use thereof |
Mar. 31, 1998 |
| 5733548 |
Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
Mar. 31, 1998 |
| 5733760 |
Salmonella vectors encoding truncated pag fusion protein, method of making, and uses thereof |
Mar. 31, 1998 |
|
|
|
